Exscientia to Report First Quarter 2024 Financial Results on May 21, 2024

Rhea-AI Summary

Exscientia (Nasdaq: EXAI) will announce its first quarter 2024 financial results on May 21, 2024, before U.S. market opening.

The company will host a conference call and webcast at 1:30 p.m. BST / 8:30 a.m. EDT to discuss business updates and review the financial outcomes.

Investors can access the webcast through the 'Investors and Media' section on Exscientia's website or dial in using provided phone numbers and conference ID.

A replay will be available for 90 days in the 'Events and Presentations' part of the site.

Positive

• Exscientia is proactively engaging investors by hosting a conference call and webcast to discuss Q1 2024 financial results.
• The availability of a 90-day replay offers extended accessibility for investors who cannot attend the live session.

Negative

• No specific financial data or performance metrics for Q1 2024 are provided in the announcement.
• Potential investors might be cautious due to the lack of detailed preliminary financial performance insights in the press release.

Company to host conference call and webcast on May 21, 2024, at 1:30 p.m. BST / 8:30 a.m. EDT

OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) will report financial results for the first quarter ended March 31, 2024, on Tuesday, May 21, 2024, before the open of U.S. markets. The Company will host a conference call and webcast at 1:30 p.m. BST / 8:30 a.m. EDT to provide a business update and review financial results.

A webcast of the live call can be accessed by visiting the “Investors and Media” section of the Company’s website at investors.exscientia.ai. Alternatively, the live conference call can be accessed by dialing +1 (888) 330 3292 (U.S.), +44 (800) 358 0970 (U.K.), +1 (646) 960 0857 (International) and entering the conference ID: 8333895. A replay will be available for 90 days under “Events and Presentations” in the “Investors and Media” section of the Exscientia website.

About Exscientia

Exscientia is an AI-driven precision medicine company committed to discovering, designing, and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.

For more information visit us on www.exscientia.ai or follow us on LinkedIn @ex-scientia and X @exscientiaAI.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240514601711/en/

Investor Relations Contact:

Sara Sherman / Chinedu Okeke

investors@exscientia.ai



Media Contact:

Oliver Stohlmann

media@exscientia.ai

Source: Exscientia plc

FAQ

When will Exscientia report its first quarter 2024 financial results?

Exscientia will report its first quarter 2024 financial results on May 21, 2024, before U.S. markets open.

How can I access Exscientia's Q1 2024 financial results conference call?

The conference call can be accessed through the 'Investors and Media' section on Exscientia's website or by dialing the provided phone numbers with the conference ID 8333895.

At what time is the Exscientia Q1 2024 financial results webcast?

The webcast will be held at 1:30 p.m. BST / 8:30 a.m. EDT on May 21, 2024.

How long will the replay of Exscientia's Q1 2024 financial results call be available?

The replay will be available for 90 days in the 'Events and Presentations' section of Exscientia's website.